Compare · KIDS vs RMD
KIDS vs RMD
Side-by-side comparison of OrthoPediatrics Corp. (KIDS) and ResMed Inc. (RMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both KIDS and RMD operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- RMD is the larger of the two at $31.73B, about 56.1x KIDS ($566.1M).
- Over the past year, KIDS is up 11.6% and RMD is down 18.8% - KIDS leads by 30.4 points.
- Both names hit the wire about 8 times in the past 4 weeks.
- RMD has more recent analyst coverage (25 ratings vs 8 for KIDS).
- Company
- OrthoPediatrics Corp.
- ResMed Inc.
- Price
- $21.54-0.62%
- $219.58-0.23%
- Market cap
- $566.1M
- $31.73B
- 1M return
- -11.23%
- -2.30%
- 1Y return
- +11.64%
- -18.79%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2017
- News (4w)
- 8
- 8
- Recent ratings
- 8
- 25
OrthoPediatrics Corp.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Latest KIDS
- Director Pelizzon David R sold $6,352,773 worth of shares (302,369 units at $21.01) (SEC Form 4)
- Large owner Squadron Capital Llc sold $7,761,194 worth of shares (336,831 units at $23.04) (SEC Form 4)
- Large owner Pritzker Jennifer N. sold $7,761,194 worth of shares (336,831 units at $23.04) (SEC Form 4)
- Director Pelizzon David R sold $7,761,194 worth of shares (336,831 units at $23.04) (SEC Form 4)
- Large owner Pritzker Jennifer N. sold $943,302 worth of shares (38,300 units at $24.63) (SEC Form 4)
- Large owner Squadron Capital Llc sold $943,302 worth of shares (38,300 units at $24.63) (SEC Form 4)
- Director Pelizzon David R sold $943,302 worth of shares (38,300 units at $24.63) (SEC Form 4)
- OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations
- SEC Form 10-Q filed by OrthoPediatrics Corp.
- OrthoPediatrics Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
Latest RMD
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,110,191 worth of ResMed Common Stock (4,991 units at $222.44) as part of a pre-agreed trading plan (SEC Form 4)
- Director Farrell Peter C sold $227,688 worth of ResMed Common Stock (970 units at $234.73) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 51,803 units (SEC Form 4)
- SEC Form 8-K filed by ResMed Inc.
- Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference
- 23XI Racing NASCAR Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams Up with Resmed to Help Others Recognize the Signs
- Rothschild & Co Redburn initiated coverage on ResMed with a new price target
- SEC Form 8-K filed by ResMed Inc.
- Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
- SEC Form 10-K filed by ResMed Inc.
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,026,596 worth of ResMed Common Stock (4,991 units at $205.69) as part of a pre-agreed trading plan (SEC Form 4)